vs

Side-by-side financial comparison of MOTORCAR PARTS OF AMERICA INC (MPAA) and PROASSURANCE CORP (PRA). Click either name above to swap in a different company.

PROASSURANCE CORP is the larger business by last-quarter revenue ($269.6M vs $167.7M, roughly 1.6× MOTORCAR PARTS OF AMERICA INC). PROASSURANCE CORP runs the higher net margin — 12.4% vs 1.1%, a 11.3% gap on every dollar of revenue. On growth, PROASSURANCE CORP posted the faster year-over-year revenue change (-7.1% vs -9.9%). Over the past eight quarters, PROASSURANCE CORP's revenue compounded faster (-2.7% CAGR vs -5.9%).

Toyota Motor North America (TMNA) is the operating subsidiary that oversees all operations of the Toyota Motor Corporation in Canada, Mexico, and the United States. Its operations include research and development, manufacturing, sales, marketing, after sales and corporate functions, which are controlled by TMNA but sometimes executed by other subsidiaries and holding companies. The company is headquartered in Plano, Texas, with offices in several locations including Georgetown, Kentucky, Ann ...

ProAssurance Corporation, headquartered in Birmingham, Alabama, is a property and casualty company that sells professional liability insurance to doctors. The company was founded in 1976 as Mutual Assurance and was later renamed to Medical Assurance in 1997. The name "ProAssurance" was created in 2001 when Medical Assurance merged with Professionals Group. The company is currently the fourth largest medical professional liability insurance writer and has over $6 billion in assets.

MPAA vs PRA — Head-to-Head

Bigger by revenue
PRA
PRA
1.6× larger
PRA
$269.6M
$167.7M
MPAA
Growing faster (revenue YoY)
PRA
PRA
+2.9% gap
PRA
-7.1%
-9.9%
MPAA
Higher net margin
PRA
PRA
11.3% more per $
PRA
12.4%
1.1%
MPAA
Faster 2-yr revenue CAGR
PRA
PRA
Annualised
PRA
-2.7%
-5.9%
MPAA

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
MPAA
MPAA
PRA
PRA
Revenue
$167.7M
$269.6M
Net Profit
$1.8M
$33.4M
Gross Margin
19.6%
Operating Margin
5.0%
17.3%
Net Margin
1.1%
12.4%
Revenue YoY
-9.9%
-7.1%
Net Profit YoY
-22.4%
106.4%
EPS (diluted)
$0.09
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MPAA
MPAA
PRA
PRA
Q4 25
$167.7M
$269.6M
Q3 25
$221.5M
$279.6M
Q2 25
$188.4M
$276.8M
Q1 25
$193.1M
$272.1M
Q4 24
$186.2M
$290.1M
Q3 24
$208.2M
$285.3M
Q2 24
$169.9M
$290.4M
Q1 24
$189.5M
$284.7M
Net Profit
MPAA
MPAA
PRA
PRA
Q4 25
$1.8M
$33.4M
Q3 25
$-2.1M
$1.4M
Q2 25
$3.0M
$21.9M
Q1 25
$-722.0K
$-5.8M
Q4 24
$2.3M
$16.2M
Q3 24
$-3.0M
$16.4M
Q2 24
$-18.1M
$15.5M
Q1 24
$1.3M
$4.6M
Gross Margin
MPAA
MPAA
PRA
PRA
Q4 25
19.6%
Q3 25
19.3%
Q2 25
18.0%
Q1 25
19.9%
Q4 24
24.1%
Q3 24
19.8%
Q2 24
17.2%
Q1 24
18.4%
Operating Margin
MPAA
MPAA
PRA
PRA
Q4 25
5.0%
17.3%
Q3 25
7.4%
1.6%
Q2 25
10.7%
9.9%
Q1 25
8.4%
-2.3%
Q4 24
9.4%
6.5%
Q3 24
6.0%
7.4%
Q2 24
-3.8%
6.2%
Q1 24
6.4%
1.9%
Net Margin
MPAA
MPAA
PRA
PRA
Q4 25
1.1%
12.4%
Q3 25
-1.0%
0.5%
Q2 25
1.6%
7.9%
Q1 25
-0.4%
-2.1%
Q4 24
1.2%
5.6%
Q3 24
-1.4%
5.8%
Q2 24
-10.6%
5.3%
Q1 24
0.7%
1.6%
EPS (diluted)
MPAA
MPAA
PRA
PRA
Q4 25
$0.09
$0.65
Q3 25
$-0.11
$0.03
Q2 25
$0.15
$0.42
Q1 25
$-0.03
$-0.11
Q4 24
$0.11
$0.32
Q3 24
$-0.15
$0.32
Q2 24
$-0.92
$0.30
Q1 24
$0.06
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MPAA
MPAA
PRA
PRA
Cash + ST InvestmentsLiquidity on hand
$19.6M
$36.5M
Total DebtLower is stronger
$420.4M
Stockholders' EquityBook value
$258.5M
$1.3B
Total Assets
$991.3M
$5.4B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MPAA
MPAA
PRA
PRA
Q4 25
$19.6M
$36.5M
Q3 25
$17.7M
$54.5M
Q2 25
$14.5M
$41.6M
Q1 25
$11.3M
$43.5M
Q4 24
$12.7M
$54.9M
Q3 24
$12.3M
$45.3M
Q2 24
$9.4M
$36.9M
Q1 24
$15.8M
$65.4M
Total Debt
MPAA
MPAA
PRA
PRA
Q4 25
$420.4M
Q3 25
$421.5M
Q2 25
$422.6M
Q1 25
$423.7M
Q4 24
$424.9M
Q3 24
$425.9M
Q2 24
$426.9M
Q1 24
$427.8M
Stockholders' Equity
MPAA
MPAA
PRA
PRA
Q4 25
$258.5M
$1.3B
Q3 25
$258.5M
$1.3B
Q2 25
$260.1M
$1.3B
Q1 25
$257.7M
$1.2B
Q4 24
$262.7M
$1.2B
Q3 24
$264.0M
$1.2B
Q2 24
$267.2M
$1.1B
Q1 24
$285.1M
$1.1B
Total Assets
MPAA
MPAA
PRA
PRA
Q4 25
$991.3M
$5.4B
Q3 25
$990.0M
$5.6B
Q2 25
$973.4M
$5.5B
Q1 25
$957.6M
$5.5B
Q4 24
$949.5M
$5.6B
Q3 24
$986.2M
$5.7B
Q2 24
$978.0M
$5.6B
Q1 24
$1.0B
$5.7B
Debt / Equity
MPAA
MPAA
PRA
PRA
Q4 25
0.31×
Q3 25
0.32×
Q2 25
0.33×
Q1 25
0.34×
Q4 24
0.35×
Q3 24
0.35×
Q2 24
0.38×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MPAA
MPAA
PRA
PRA
Operating Cash FlowLast quarter
$-8.2M
$-25.6M
Free Cash FlowOCF − Capex
$-8.6M
FCF MarginFCF / Revenue
-5.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
-4.63×
-0.77×
TTM Free Cash FlowTrailing 4 quarters
$27.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MPAA
MPAA
PRA
PRA
Q4 25
$-8.2M
$-25.6M
Q3 25
$21.9M
$27.2M
Q2 25
$10.0M
$-28.1M
Q1 25
$9.1M
$-11.6M
Q4 24
$34.4M
$-10.7M
Q3 24
$22.9M
$14.0M
Q2 24
$-20.8M
$-12.8M
Q1 24
$-9.3M
$-11.6M
Free Cash Flow
MPAA
MPAA
PRA
PRA
Q4 25
$-8.6M
Q3 25
$20.8M
Q2 25
$9.2M
Q1 25
$6.2M
Q4 24
$33.7M
Q3 24
$22.3M
Q2 24
$-21.3M
Q1 24
$-9.8M
FCF Margin
MPAA
MPAA
PRA
PRA
Q4 25
-5.2%
Q3 25
9.4%
Q2 25
4.9%
Q1 25
3.2%
Q4 24
18.1%
Q3 24
10.7%
Q2 24
-12.6%
Q1 24
-5.2%
Capex Intensity
MPAA
MPAA
PRA
PRA
Q4 25
0.2%
Q3 25
0.5%
Q2 25
0.4%
Q1 25
1.5%
Q4 24
0.4%
Q3 24
0.3%
Q2 24
0.3%
Q1 24
0.3%
Cash Conversion
MPAA
MPAA
PRA
PRA
Q4 25
-4.63×
-0.77×
Q3 25
18.81×
Q2 25
3.30×
-1.28×
Q1 25
Q4 24
15.00×
-0.66×
Q3 24
0.85×
Q2 24
-0.83×
Q1 24
-6.93×
-2.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MPAA
MPAA

Reportable Segment Aggregation Before Other Operating Segment$156.3M93%
Other$11.4M7%

PRA
PRA

Workers Compensation Insurance Segment$164.4M61%
Other$59.6M22%
Segregated Portfolio Cell Reinsurance$45.7M17%

Related Comparisons